| Ruthenium metallopharmaceuticals MJ Clarke Coordination Chemistry Reviews 236 (1-2), 209-233, 2003 | 1454 | 2003 |
| Non-platinum chemotherapeutic metallopharmaceuticals MJ Clarke, F Zhu, DR Frasca Chemical Reviews 99 (9), 2511-2533, 1999 | 1199 | 1999 |
| Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials J Bohlius, K Schmidlin, C Brillant, G Schwarzer, S Trelle, J Seidenfeld, ... The Lancet 373 (9674), 1532-1542, 2009 | 723 | 2009 |
| The design and implementation of Open ORB 2 GS Blair, G Coulson, A Andersen, L Blair, M Clarke, F Costa, ... IEEE Distributed Systems Online 2 (6), 1-40, 2001 | 379 | 2001 |
| Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling M Clarke, AJ Lohan, B Liu, I Lagkouvardos, S Roy, N Zafar, C Bertelli, ... Genome biology 14, 1-15, 2013 | 325 | 2013 |
| An efficient component model for the construction of adaptive middleware M Clarke, GS Blair, G Coulson, N Parlavantzas Middleware 2001: IFIP/ACM International Conference on Distributed Systems …, 2001 | 277 | 2001 |
| Oncological implications of the chemistry of ruthenium MJ Clarke Metal ions in biological systems 11, 231-283, 1980 | 265 | 1980 |
| The design of a configurable and reconfigurable middleware platform G Coulson, GS Blair, M Clarke, N Parlavantzas Distributed Computing 15, 109-126, 2002 | 235 | 2002 |
| Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex WL Ying, J Emerson, MJ Clarke, DR Sanadi Biochemistry 30 (20), 4949-4952, 1991 | 195 | 1991 |
| Reduction and subsequent binding of ruthenium ions catalyzed by subcellular components MJ Clarke, S Bitler, D Rennert, M Buchbinder, AD Kelman Journal of inorganic biochemistry 12 (1), 79-87, 1980 | 177 | 1980 |
| A controlled NO-releasing compound: synthesis, molecular structure, spectroscopy, electrochemistry, and chemical reactivity of R, R, S, S-trans-[RuCl (NO)(cyclam)] 2+(1, 4, 8 … DR Lang, JA Davis, LGF Lopes, AA Ferro, LCG Vasconcellos, DW Franco, ... Inorganic chemistry 39 (11), 2294-2300, 2000 | 176 | 2000 |
| Medical diagnostic imaging with complexes of 99mTc MJ Clarke, L Podbielski Coordination chemistry reviews 78, 253-331, 1987 | 175 | 1987 |
| Electrochemistry, synthesis, and spectra of pentaammineruthenium (III) complexes of cytidine, adenosine, and related ligands MJ Clarke Journal of the American Chemical Society 100 (16), 5068-5075, 1978 | 150 | 1978 |
| Chemistry relevant to the biological effects of nitric oxide and metallonitrosyls MJ Clarke, JB Gaul Structures and Biological Effects, 147-181, 2005 | 121 | 2005 |
| Effects of hypoxia and transferrin on toxicity and DNA binding of ruthenium antitumor agents in HeLa cells D Frasca, J Ciampa, J Emerson, RS Umans, MJ Clarke Metal-Based Drugs 3 (4), 197, 1996 | 112 | 1996 |
| Biochemical effects of binding [(H2O)(NH3) 5RuII] 2+ to DNA and oxidation to [(NH3) 5RuIII] n—DNA. MJ Clarke, B Jansen, KA Marx, R Kruger Inorganica chimica acta 124 (1), 13-28, 1986 | 99 | 1986 |
| Nitrogen-bound and carbon-bound xanthine complexes of ruthenium ammines MJ Clarke, H Taube Journal of the American Chemical Society 97 (6), 1397-1403, 1975 | 96 | 1975 |
| Alterations in the binding of [Cl (NH3) 5RuIII] 2+ to DNA by glutathione: reduction, autoxidation, coordination, and decomposition DR Frasca, MJ Clarke Journal of the American Chemical Society 121 (37), 8523-8532, 1999 | 94 | 1999 |
| Pentaammineruthenium-guanine complexes MJ Clarke, H Taube Journal of the American Chemical Society 96 (17), 5413-5419, 1974 | 93 | 1974 |
| Mutagenic and toxic effects of ruthenium RE Yasbin, CR Matthews, MJ Clarke Chemico-Biological Interactions 31 (3), 355-365, 1980 | 92 | 1980 |
